Silverlake Wealth Management’s Amgen AMGN Stock Holding History

Silverlake Wealth Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.58M	Sell	4,478 -70	-2%	-$25K	0.33%	96
2025 Q4	$1.49M	Sell	4,548 -59	-1%	-$18.7K	0.33%	96
2025 Q3	$1.3M	Sell	4,607 -50	-1%	-$14.5K	0.32%	100
2025 Q2	$1.3M	Buy	4,657 +356	+8%	+$101K	0.38%	83
2025 Q1	$1.34M	Sell	4,301 -113	-3%	-$33.4K	0.51%	59
2024 Q4	$1.15M	Sell	4,414 -495	-10%	-$147K	0.44%	64
2024 Q3	$1.58M	Buy	4,909 +99	+2%	+$32.4K	0.6%	46
2024 Q2	$1.5M	Sell	4,810 -189	-4%	-$55.5K	0.62%	45
2024 Q1	$1.42M	Buy	4,999 +39	+0.8%	+$11.4K	0.72%	34
2023 Q4	$1.43M	Sell	4,960 -1,181	-19%	-$322K	0.79%	29
2023 Q3	$1.65M	Buy	6,141 +68	+1%	+$17K	0.93%	22
2023 Q2	$1.35M	Buy	6,073 +75	+1%	+$17.4K	0.75%	30
2023 Q1	$1.45M	Buy	5,998 +622	+12%	+$153K	0.88%	27
2022 Q4	$1.41M	Buy	5,376 +10	+0.2%	+$2.68K	0.88%	25
2022 Q3	$1.21M	Sell	5,366 -16	-0.3%	-$3.88K	0.82%	30
2022 Q2	$1.31M	Buy	5,382 +37	+0.7%	+$9.07K	0.85%	26
2022 Q1	$1.29M	Buy	5,345 +2	+0%	+$460	0.74%	34
2021 Q4	$1.2M	Buy	+5,343	New	+$1.13M	0.65%	41

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Silverlake Wealth Management's AMGN Position: Q1 2026 in Review

Silverlake Wealth Management reduced its Amgen (AMGN) stake by 1.5% in Q1 2026, selling an estimated $25K and leaving 4,478 shares worth $1.58M. The position accounts for 0.33% of the portfolio, ranked #96.

Silverlake Wealth Management first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.65M in Q3 2023. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Silverlake Wealth Management held 4,478 shares of Amgen worth $1.58M as of Q1 2026.
Silverlake Wealth Management sold 70 Amgen shares in Q1 2026, an estimated $25K.
Amgen made up 0.33% of Silverlake Wealth Management's portfolio in Q1 2026, its #96 holding.
Silverlake Wealth Management first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
Silverlake Wealth Management's Amgen position peaked at $1.65M in Q3 2023.
3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Silverlake Wealth Management's 13F filing for Q1 2026, filed 15 Apr 2026.